Form 4: Vera Therapeutics CMO Sells Shares for Tax Obligations

Vera Therapeutics' Chief Medical Officer, Robert Brenner, sold 2,151 shares of Class A Common Stock to cover tax withholding obligations related to RSU vesting.

Summary

• Robert Brenner, Chief Medical Officer of Vera Therapeutics, Inc. (VERA), reported a transaction involving the sale of Class A Common Stock.
• A total of 2,151 shares were sold at a weighted-average price of $41.9839 per share.
• The sale was executed over two business days, from February 23, 2026, to February 24, 2026.
• The transaction was a 'sell-to-cover' sale, mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations incurred upon the vesting of restricted stock units (RSUs).
• This sale does not represent a discretionary trade by the reporting person.
• Following the reported transaction, Robert Brenner beneficially owns 50,947 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was non-discretionary and solely for tax withholding purposes related to RSU vesting, which is a common practice for executive compensation.

Industry Context

StockSavvy.ai notes that 'sell-to-cover' transactions are a common and routine mechanism for executives to satisfy tax liabilities arising from the vesting of restricted stock units, and typically do not reflect a discretionary investment decision or a change in management's outlook on the company's prospects.

Key Dates

Keywords

Vera Therapeutics, VERA, Form 4, Insider Trading, Stock Sale, RSU, Tax Withholding, Chief Medical Officer